Mirtazapin Orion (Mirtazapine)

Mirtazapine works by blocking presynaptic α2‑adrenergic receptors, which increases the release of norepinephrine, and by antagonising postsynaptic serotonin 5‑HT2 and 5‑HT3 receptors as well as histamine H1 receptors. This combined action raises serotonin and norepinephrine levels while providing a sedative effect, contributing to its antidepressant properties.

The appropriate dose of Mirtazapin Orion is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and tolerability. Dosage may be adjusted over time, and patients should follow the specific instructions provided by their healthcare professional.

Safety data for mirtazapine in pregnancy and lactation are limited. The drug should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers will evaluate each case individually and discuss potential risks and alternatives.

To order Mirtazapin Orion, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mirtazapin Orion (mirtazapine) belongs to the NaSSA class, whereas SSRIs primarily inhibit serotonin reuptake. Mirtazapine often causes more sedation and weight gain but may be preferred when patients experience insomnia or need an alternative to SSRIs. Efficacy in relieving depressive symptoms is comparable, but side‑effect profiles differ.

Mirtazapin Orion should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiry date indicated on the label.

Mirtazapin Orion is taken orally, usually once daily in the evening with or without food, as directed by a healthcare professional. Swallow the tablet whole with a glass of water; do not crush, chew, or split the tablet unless specifically instructed by the prescriber.

Serious risks include the potential for agranulocytosis or severe neutropenia, hepatic dysfunction, and the emergence or worsening of suicidal thoughts, particularly during the initial weeks of therapy. Patients should be monitored closely for any signs of infection, liver problems, or changes in mood.

Mirtazapin Orion should be avoided in individuals with known hypersensitivity to mirtazapine or any of its excipients. Caution is also advised for patients taking monoamine oxidase inhibitors, those with severe hepatic impairment, or anyone with a history of severe allergic reactions to similar antidepressants.